Skip to main content
High RiskFDAfda-F-2420-2015OTHER

Seasoning Fish Filet Ingredients: Mixed Fish, Sugar, Salt, Monosodium Glutamate, Sorbic Acid Bulk cases with 12kg of fish fillets w...

Category
Units Affected
148
Recall Date
April 23, 2015
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2420-2015.

Roxy Trading, Inc. is recalling Seasoning Fish Filet due to the label missing an ingredient statement. Also, the fish was labeled as Grouper when it has been confirmed to be a mixture of fish.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2420-2015.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Roxy Trading Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2420-2015.

Roxy Trading Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Roxy Trading Inc Recall FAQ

Roxy Trading Inc is the subject of a seafood safety report: Seasoning Fish Filet Ingredients: Mixed Fish, Sugar, Salt, Monosodium Glutamate, Sorbic Acid Bulk cases with 12kg of fish fillets w.... The notice was published on April 23, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 148 units are potentially affected.